Inactive Instrument

News COSMO Pharmaceuticals SA Swiss Exchange

Equities

LU1202320294

End-of-day quote Swiss Exchange Other stock markets
- ^CHF	-

Apr. 26	Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	CI
Apr. 25	Cosmo Pharmaceuticals Names New CEO, Chairman	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	Apr. 26	CI
Cosmo Pharmaceuticals Names New CEO, Chairman	Apr. 25	MT
Cosmo Announces Leadership Changes	Apr. 25	NE
Cosmo and Medtronic unveil the future of AI in GI, Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care	Apr. 15	AQ
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care	Apr. 12	NE
Cosmo and Medtronic unveil the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care	Apr. 12	PU
Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day	Mar. 20
Cosmo Pharmaceuticals N.V. Proposes Dividend Payment for 2024	Mar. 20	CI
Cosmo Pharmaceuticals N.V. Provides Earnings Guidance for the Year 2024 and Revenue Guidance for 2025	Mar. 20	CI
Transcript : Cosmo Pharmaceuticals N.V., 2023 Earnings Call, Mar 20, 2024	Mar. 20
Cosmo Pharmaceuticals N : ESG Report 2023	Mar. 20	PU
Cosmo Reports Excellent Preliminary Unaudited Full Year 2023 Core Financial Results - Record Guidance for 2024 - Doubles Dividend to 2.00 per Share	Mar. 20	NE
Cosmo Pharmaceuticals' FY23 Profit, Revenue Drops	Mar. 20	MT
Cosmo Pharmaceuticals N : reports excellent preliminary unaudited Full Year 2023 core financial results – Record guidance for 2024 – Doubles dividend to € 2.00 per share	Mar. 20	PU
Cosmo Pharmaceuticals N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia	Mar. 19	MT
Cosmo Pharmaceuticals Announces Approval of Winlevi(R) in Australia	Mar. 19	NE
Cosmo Pharmaceuticals N : announces approval of Winlevi® in Australia	Mar. 19	PU
Invitation to Cosmo's Investor Day and Full-Year 2023 Webcast, Zurich, 20 March 2024	Jan. 26	AQ
Invitation to Cosmo's Investor Day and Full-Year 2023 Webcast - Zurich, 20 March 2024	Jan. 25	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News COSMO Pharmaceuticals SA Swiss Exchange

Equities

LU1202320294

Summary

Filters